U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Draft Guidance for Industry: Foreign Supplier Verification Programs for Importers of Food for Humans and Animals
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Draft Guidance for Industry: Foreign Supplier Verification Programs for Importers of Food for Humans and Animals January 2018

Draft

Not for implementation. Contains non-binding recommendations.

Docket Number:
FDA-2017-D-5225
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine
Office of Regulatory Affairs
Center for Food Safety and Applied Nutrition

The purpose of this document is to provide guidance for industry on the requirements for a foreign supplier verification program (FSVP) in 21 CFR part 1, subpart L, that importers of human or animal food must establish and follow to ensure that each food they import into the United States meets applicable U.S. requirements and is not adulterated or (for human food) misbranded with respect to allergen labeling.

FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities.  Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.  

The use of the word should in Agency guidances means that something is suggested or recommended, but not required.

This guidance provides questions and answers to facilitate importers’ understanding of the FSVP requirements.

Download the Draft Guidance


Related Information


Questions?

For questions regarding this draft document, contact the Office of Compliance, Center for Food Safety and Applied Nutrition (CFSAN), at 240-701-5986 (regarding human food), or the Office of Surveillance and Compliance, Center for Veterinary Medicine (CVM), at 240-402-6246 (regarding animal food).


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2017-D-5225.

Back to Top